TOO MANY OF OUR LOVED ONES ARE DYING OF CANCER. Despite many of the advancements in healthcare, most cancers are diagnosed in the late stages of disease progression when treatments are less effective, resulting in unacceptably low survival rates.The entire Preora Healthcare team approaches each day with a clear mission: dramatically improve patient survival rates through the early detection and treatment of cancer.
Preora’s PWS Nanocytology™ platform detects early cellular changes at the nanoscale level that cause cancer, and the corresponding impact on treatments for cancer. The platform is composed of includes three core technologies, from sample preparation to analysis, that will increase the depth and quality of clinically relevant information. For more information, visit our Opportunities page.
Early Cancer Detection: The Key to Saving Lives Dr. Backman’s opening remarks at the Milken Institute highlighted the value of two-tiered cancer screening